User menu

Parameters controlling topical delivery of oligonucleotides by electroporation.

Bibliographic reference Regnier, Vincent ; Le Doan, T ; Préat, Véronique. Parameters controlling topical delivery of oligonucleotides by electroporation.. In: Journal of drug targeting, Vol. 5, no. 4, p. 275-89 (1998)
Permanent URL
  1. Akhtar S., Kole R., Juliano R.L., Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera, 10.1016/0024-3205(91)90480-y
  2. Bazile D., Mir L.M., Paoletti C., Voltage-dependent introduction of a d[α]octothymidylate into electropermeabilized cells, 10.1016/0006-291x(89)90041-7
  3. Jean Belehradek Jr., Orlowski Stéphane, Ramirez Luis H., Pron Géraldine, Poddevin Bruno, Mir Lluis M., Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin, 10.1016/0005-2736(94)90045-0
  4. Bergan Raymond, Connell Yvette, Fahmy Brigid, Neckers Leonard, Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy, 10.1093/nar/21.15.3567
  5. Bommannan D. Bommi, Tamada Janet, Leung Lewis, Potts Russell O., 10.1023/a:1018983804635
  6. Brand Rhonda M., Iversen Patrick L., 10.1023/a:1016092809914
  7. Crooke S, Pharm. News, 2, 8 (1995)
  8. Crooke S T, Bennett C F, Progress in Antisense Oligonucleotide Therapeutics, 10.1146/
  9. Edwards David A., Prausnitz Mark R., Langer Robert, Weaver James C., Analysis of enhanced transdermal transport by skin electroporation, 10.1016/0168-3659(94)00132-e
  10. Fynan E. F., Webster R. G., Fuller D. H., Haynes J. R., Santoro J. C., Robinson H. L., DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations., 10.1073/pnas.90.24.11478
  11. Gillardon F., Oncogene, 9, 3219 (1994)
  12. Goodchild J, Oligonucleotides: Anti-sense Inhibitors of Gene Expression, 53 (1989)
  13. Graham M.J., Freier S.M., Crooke R.M., Ecker D.J., maslova R.N., Lesnik E.a., Tritium labeling of antisense oligonucleotides by exchange with tritiated water, 10.1093/nar/21.16.3737
  14. Heller Richard, Jaroszeski Mark J., Glass L. Frank, Messina Jane L., Rapaport David P., DeConti Ronald C., Fenske Neil A., Gilbert Richard A., Mir Lluis M., Reintgen Douglas S., Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy, 10.1002/(sici)1097-0142(19960301)77:5<964::aid-cncr24>;2-0
  15. Jadoul A, Skin perturbations induced by iontophoresis and electroporation: enhancement in drug transport and integrity of the stratum corneum (1997)
  16. Marks R., Barton S. P., The Significance of the Size and Shape of Corneocytes, Stratum Corneum (1983) ISBN:9783540117049 p.161-170, 10.1007/978-3-642-68682-5_18
  17. Nolen H.W., Catz P., Friend D.R., Percutaneous penetration of methyl phosphonate antisense oligonucleotides, 10.1016/0378-5173(94)90431-6
  18. Oldenburg Kevin R., Vo Kham T., Smith Gregory A., Selick Harold E., Iontophoretic Delivery of Oligonucleotides across full Thickness Hairless Mouse Skin, 10.1002/jps.2600840803
  19. Pinkus I, Cancer of the Skin, 16 (1976)
  20. Pliquett Uwe, Weaver James C., Electroporation of human skin: simultaneous measurement of changes in the transport of two fluorescent molecules and in the passive electrical properties, 10.1016/0302-4598(95)01828-x
  21. Prausnitz M. R., Bose V. G., Langer R., Weaver J. C., Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery., 10.1073/pnas.90.22.10504
  22. Prausnitz Mark R., Pliquett Uwe, Langer Robert, Weaver James C., 10.1023/a:1018944223290
  23. Prausnitz Mark R., Edelman Elazer R., Gimm J. Aura, Langer Robert, Weaver James C., Transdermal Delivery of Heparin by Skin Electroporation, 10.1038/nbt1195-1205
  24. Prausnitz Mark R., Lee Caroline S., Liu Cindy H., Pang Judy C., Singh Tej-Preet, Langer Robert, Weaver James C., Transdermal transport efficiency during skin electroporation and iontophoresis, 10.1016/0168-3659(95)00121-2
  25. Regnier V., Pharm. Res., 13, S383 (1996)
  26. Roizman B, Inhibition of Herpesviridae infection by antisense oligonucleotides (1992)
  27. Rojanasakul Yongyut, Antisense oligonucleotide therapeutics: drug delivery and targeting, 10.1016/0169-409x(95)00020-8
  28. Rols M.P., Teissié J., Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon, 10.1016/s0006-3495(90)82451-6
  29. Sambrook J., Fritsch E. F., Maniatis T. Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press, New-York 1989; B16
  30. Shin B. C., Proceed. Int. Symp. Control. Rel. Bioact. Mater., 21, 373 (1994)
  31. Thysman Sophie, Préat Véronique, Roland Michel, Factors Affecting Iontophoretic Mobility of Metoprolol, 10.1002/jps.2600810717
  32. Titomirov Alexander V., Sukharev Sergey, Kistanova Elena, In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA, 10.1016/0167-4781(91)90162-f
  33. Tojo Kakuji, Chiang C. C., Doshi U., Chien Y. W., Stratum Corneum Reservoir Capacity Affecting Dynamics of Transdermal Drug Delivery, 10.3109/03639048809151884
  34. Vanbever Rita, Lecouturier Nathalie, Préat Véronique, 10.1023/a:1018930425591
  35. Vanbever Rita, Préat Véronique, Factors affecting transdermal delivery of metoprolol by electroporation, 10.1016/0302-4598(95)01830-8
  36. Vanbever R., Pharm. Res., 13, 557 (1996)
  37. Vanbever Rita, De Morre Nathalie, Préat Véronique, 10.1023/a:1016073917125
  38. Vanbever R, Skin electroporation for transdermal drugdelivery (1997)
  39. VLASSOV VALENTIN V., NECHAEVA MARINA V., KARAMYSHEV VALERY N., YAKUBOV LEONID A., Iontophoretic Delivery of Oligonucleotide Derivatives into Mouse Tumor, 10.1089/ard.1994.4.291
  40. Weaver J, Methods. Mol. Biol., 47, 1 (1995)
  41. Weaver J., CRC Handbook of biological effects of electromagnetic fields, Second Edition, 247 (1996)
  42. Zewert T.E., Pliquett U.F., Langer R., Weaver J.C., Transdermal Transport of DNA Antisense Oligonucleotides by Electroporation, 10.1006/bbrc.1995.1968
  43. Zhang Lei, Li Lingna, Hoffmann Günter A., Hoffman Robert M., Depth-Targeted Efficient Gene Delivery and Expression in the Skin by Pulsed Electric Fields: An Approach to Gene Therapy of Skin Aging and Other Diseases, 10.1006/bbrc.1996.0455